KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 252 filers reported holding KITE PHARMA INC in Q3 2017. The put-call ratio across all filers is 1.40 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $7,185,000 | +37.7% | 39,953 | -20.6% | 0.02% | +21.4% |
| Q2 2017 | $5,218,000 | +27.8% | 50,339 | -3.3% | 0.01% | +27.3% |
| Q1 2017 | $4,084,000 | +50.0% | 52,030 | -14.3% | 0.01% | +37.5% |
| Q4 2016 | $2,723,000 | -28.1% | 60,720 | -10.5% | 0.01% | -33.3% |
| Q3 2016 | $3,788,000 | +7.6% | 67,809 | -3.6% | 0.01% | +9.1% |
| Q2 2016 | $3,519,000 | +1.6% | 70,372 | -6.7% | 0.01% | 0.0% |
| Q1 2016 | $3,464,000 | -43.1% | 75,449 | -23.7% | 0.01% | -38.9% |
| Q4 2015 | $6,093,000 | -15.2% | 98,884 | -23.3% | 0.02% | -18.2% |
| Q3 2015 | $7,183,000 | -18.9% | 128,999 | -11.2% | 0.02% | 0.0% |
| Q2 2015 | $8,855,000 | +20.2% | 145,232 | +13.7% | 0.02% | +29.4% |
| Q1 2015 | $7,368,000 | +40.6% | 127,737 | +40.6% | 0.02% | +30.8% |
| Q4 2014 | $5,241,000 | – | 90,883 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,410,034 | $433,348,000 | 77.71% |
| COWEN INC. | 4,200,600 | $755,310,000 | 26.72% |
| Tyrus Capital S.A.M. | 1,314,812 | $236,416,000 | 18.49% |
| OMNI PARTNERS LLP | 661,711 | $118,982,000 | 15.19% |
| FNY Partners Fund LP | 379,510 | $68,239,000 | 11.61% |
| EQUITEC PROPRIETARY MARKETS, LLC | 240,100 | $43,172,000 | 10.15% |
| EQUITEC PROPRIETARY MARKETS, LLC | 227,500 | $40,907,000 | 9.62% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 773,817 | $139,140,000 | 8.89% |
| Quad Capital Management Advisors LLC | 192,537 | $34,620,000 | 7.10% |
| Avoro Capital Advisors LLC | 496,983 | $89,363,000 | 6.93% |